Barrington Research Analysts Increase Earnings Estimates for Healthequity Inc (HQY)

Healthequity Inc (NASDAQ:HQY) – Barrington Research lifted their FY2018 earnings estimates for Healthequity in a note issued to investors on Thursday. Barrington Research analyst A. Paris. Jr now forecasts that the company will post earnings per share of $0.73 for the year, up from their prior estimate of $0.70. Barrington Research also issued estimates for Healthequity’s Q4 2018 earnings at $0.06 EPS.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. During the same quarter in the previous year, the company posted $0.10 EPS. The business’s revenue for the quarter was up 31.0% compared to the same quarter last year.

Several other equities analysts also recently issued reports on HQY. BidaskClub downgraded Healthequity from a “sell” rating to a “strong sell” rating in a research report on Friday, August 25th. Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a research report on Tuesday, August 29th. Oppenheimer reiterated a “buy” rating and issued a $61.00 price objective on shares of Healthequity in a research report on Wednesday, September 6th. Robert W. Baird reiterated a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. Finally, Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a research report on Wednesday, October 11th. One analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the stock. Healthequity currently has an average rating of “Buy” and an average price target of $58.33.

Shares of Healthequity (NASDAQ HQY) traded up $0.78 on Monday, reaching $44.54. The company’s stock had a trading volume of 520,812 shares, compared to its average volume of 533,107. Healthequity has a 52-week low of $37.62 and a 52-week high of $55.31. The company has a market cap of $2,650.79, a P/E ratio of 62.41, a price-to-earnings-growth ratio of 1.81 and a beta of 1.74.

In related news, insider Stephen Neeleman sold 8,500 shares of Healthequity stock in a transaction on Friday, September 15th. The stock was sold at an average price of $45.24, for a total transaction of $384,540.00. Following the completion of the sale, the insider now directly owns 1,000 shares of the company’s stock, valued at $45,240. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction on Monday, December 4th. The stock was sold at an average price of $50.97, for a total value of $509,700.00. Following the sale, the vice president now directly owns 15,652 shares of the company’s stock, valued at $797,782.44. The disclosure for this sale can be found here. Insiders sold a total of 1,743,212 shares of company stock valued at $91,145,351 over the last three months. Insiders own 19.00% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Zions Bancorporation acquired a new stake in shares of Healthequity during the third quarter worth $119,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Healthequity by 105.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after purchasing an additional 1,308 shares during the period. Riverhead Capital Management LLC grew its stake in shares of Healthequity by 75.3% during the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after purchasing an additional 1,129 shares during the period. Oppenheimer Asset Management Inc. grew its stake in shares of Healthequity by 7.7% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after purchasing an additional 191 shares during the period. Finally, Fortaleza Asset Management Inc. acquired a new stake in shares of Healthequity during the second quarter worth $138,000. 98.60% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Barrington Research Analysts Increase Earnings Estimates for Healthequity Inc (HQY)” was first published by Week Herald and is owned by of Week Herald. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://weekherald.com/2017/12/13/barrington-research-analysts-increase-earnings-estimates-for-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply